For example, we observed amplification of KRAS. While the role of mutated KRAS in cancer and therapy resistance has been widely described, KRAS gene amplification appears to be associated with tumour phenotype rather than with the acquisition of therapy resistance [40]. Here, KRAS is linked to neoplasm.